Tim Slade1, Wai-Tat Chiu2, Meyer Glantz3, Ronald C Kessler2, Luise Lago1, Nancy Sampson2, Ali Al-Hamzawi4, Silvia Florescu5, Jacek Moskalewicz6, Sam Murphy7, Fernando Navarro-Mateu8, Yolanda Torres de Galvis9, Maria Carmen Viana10, Miguel Xavier11, Louisa Degenhardt1. 1. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia. 2. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. 3. Department of Epidemiology, Services, and Prevention Research (DESPR), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, Maryland. 4. College of Medicine, Al-Qadisiya University, Diwania governorate, Iraq. 5. National School of Public Health, Management and Professional Development, Bucharest, Romania. 6. Department of Studies on Alcoholism and Drug Dependence, Institute of Psychiatry and Neurology, Warsaw, Poland. 7. School of Psychology, University of Ulster, Belfast, Ireland. 8. IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano de Salud, El Palmar, Murcia, Spain. 9. Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia. 10. Department of Social Medicine, Federal University of Espírito Santo, Vitoria, Brazil. 11. Nova Medical School/Faculdade Ciencias Medicas-Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
Abstract
BACKGROUND: The current study sought to examine the diagnostic overlap in DSM-IV and DSM-5 alcohol use disorder (AUD) and determine the clinical correlates of changing diagnostic status across the 2 classification systems. METHODS: DSM-IV and DSM-5 definitions of AUD were compared using cross-national community survey data in 9 low-, middle-, and high-income countries. Participants were 31,367 respondents to surveys in the World Health Organization's World Mental Health Survey Initiative. The Composite International Diagnostic Interview, version 3.0, was used to derive DSM-IV and DSM-5 lifetime diagnoses of AUD. Clinical characteristics, also assessed in the surveys, included lifetime DSM-IV anxiety; mood and drug use disorders; lifetime suicidal ideation, plan, and attempt; general functional impairment; and psychological distress. RESULTS: Compared with DSM-IV AUD (12.3%, SE = 0.3%), the DSM-5 definition yielded slightly lower prevalence estimates (10.8%, SE = 0.2%). Almost one-third (n = 802) of all DSM-IV abuse cases switched to subthreshold according to DSM-5 and one-quarter (n = 467) of all DSM-IV diagnostic orphans switched to mild AUD according to DSM-5. New cases of DSM-5 AUD were largely similar to those who maintained their AUD across both classifications. Similarly, new DSM-5 noncases were similar to those who were subthreshold across both classifications. The exception to this was with regard to the prevalence of any lifetime drug use disorder. CONCLUSIONS: In this large cross-national community sample, the prevalence of DSM-5 lifetime AUD was only slightly lower than the prevalence of DSM-IV lifetime AUD. Nonetheless, there was considerable diagnostic switching, with a large number of people inconsistently identified across the 2 DSM classifications.
BACKGROUND: The current study sought to examine the diagnostic overlap in DSM-IV and DSM-5 alcohol use disorder (AUD) and determine the clinical correlates of changing diagnostic status across the 2 classification systems. METHODS: DSM-IV and DSM-5 definitions of AUD were compared using cross-national community survey data in 9 low-, middle-, and high-income countries. Participants were 31,367 respondents to surveys in the World Health Organization's World Mental Health Survey Initiative. The Composite International Diagnostic Interview, version 3.0, was used to derive DSM-IV and DSM-5 lifetime diagnoses of AUD. Clinical characteristics, also assessed in the surveys, included lifetime DSM-IV anxiety; mood and drug use disorders; lifetime suicidal ideation, plan, and attempt; general functional impairment; and psychological distress. RESULTS: Compared with DSM-IV AUD (12.3%, SE = 0.3%), the DSM-5 definition yielded slightly lower prevalence estimates (10.8%, SE = 0.2%). Almost one-third (n = 802) of all DSM-IV abuse cases switched to subthreshold according to DSM-5 and one-quarter (n = 467) of all DSM-IV diagnostic orphans switched to mild AUD according to DSM-5. New cases of DSM-5 AUD were largely similar to those who maintained their AUD across both classifications. Similarly, new DSM-5 noncases were similar to those who were subthreshold across both classifications. The exception to this was with regard to the prevalence of any lifetime drug use disorder. CONCLUSIONS: In this large cross-national community sample, the prevalence of DSM-5 lifetime AUD was only slightly lower than the prevalence of DSM-IV lifetime AUD. Nonetheless, there was considerable diagnostic switching, with a large number of people inconsistently identified across the 2 DSM classifications.
Authors: Meyer D Glantz; Maria Elena Medina-Mora; Maria Petukhova; Laura Helena Andrade; James C Anthony; Giovanni de Girolamo; Ron de Graaf; Louisa Degenhardt; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Itsuko Horiguchi; Elie G Karam; Stanislav Kostyuchenko; Sing Lee; Jean-Pierre Lépine; Herbert Matschinger; Yehuda Neumark; Jose Posada-Villa; Rajesh Sagar; Dan J Stein; Toma Tomov; J Elisabeth Wells; Somnath Chatterji; Ronald C Kessler Journal: Am J Addict Date: 2013-08-29
Authors: Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Kevin E O'Grady; Robert P Schwartz Journal: Drug Alcohol Depend Date: 2014-04-13 Impact factor: 4.492
Authors: Louisa Degenhardt; Chrianna Bharat; Raimondo Bruno; Meyer D Glantz; Nancy A Sampson; Luise Lago; Sergio Aguilar-Gaxiola; Jordi Alonso; Laura Helena Andrade; Brendan Bunting; Jose Miguel Caldas-de-Almeida; Alfredo H Cia; Oye Gureje; Elie G Karam; Mohammad Khalaf; John J McGrath; Jacek Moskalewicz; Sing Lee; Zeina Mneimneh; Fernando Navarro-Mateu; Carmen C Sasu; Kate Scott; Yolanda Torres; Vladimir Poznyak; Somnath Chatterji; Ronald C Kessler Journal: Addiction Date: 2018-12-09 Impact factor: 6.526
Authors: Louisa Degenhardt; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; José Miguel Caldas-de-Almeida; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep M Haro; Elie G Karam; Georges Karam; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Victor Makanjuola; Maria E Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; Marina Piazza; José Posada-Villa; Nancy A Sampson; Kate M Scott; Juan Carlos Stagnaro; Margreet Ten Have; Kenneth S Kendler; Ronald C Kessler; John J McGrath Journal: Addiction Date: 2018-02-21 Impact factor: 6.526
Authors: Louisa Degenhardt; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Kate Scott; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Meredith G Harris; Yanling He; Peter de Jonge; Elie G Karam; Georges E Karam; Andrzej Kiejna; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Victor Makanjuola; Maria Elena Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; José Posada-Villa; Dan J Stein; Hisateru Tachimori; Yolanda Torres; Zahari Zarkov; Somnath Chatterji; Ronald C Kessler Journal: Int J Drug Policy Date: 2019-06-28
Authors: Esteban Calvo; José T Medina; Katherine A Ornstein; Ursula M Staudinger; Linda P Fried; Katherine M Keyes Journal: Drug Alcohol Depend Date: 2020-08-04 Impact factor: 4.492
Authors: Traci Takahashi; Gwen Lapham; Laura J Chavez; Amy K Lee; Emily C Williams; Julie E Richards; Diane Greenberg; Anna Rubinsky; Douglas Berger; Eric J Hawkins; Joseph O Merrill; Katharine A Bradley Journal: Addict Sci Clin Pract Date: 2017-07-18
Authors: Annelieke M Roest; Ymkje Anna de Vries; Carmen C W Lim; Hans-Ulrich Wittchen; Dan J Stein; Tomasz Adamowski; Ali Al-Hamzawi; Evelyn J Bromet; Maria Carmen Viana; Giovanni de Girolamo; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; José Miguel Caldas-de-Almeida; Norito Kawakami; Jean Pierre Lépine; Daphna Levinson; Maria E Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José A Posada-Villa; Tim Slade; Yolanda Torres; Ronald C Kessler; Kate M Scott; Peter de Jonge Journal: Depress Anxiety Date: 2019-02-06 Impact factor: 6.505